Abstract: A process and apparatus for electrolyte solution production can be provided so that a modular production can be provided. The modular electrolyte production can be provided so that the production system is mobile for being used in multiple different plants at different geographical locations that are remote from each other. Embodiments can be configured so that electrolyte production is made for a plant specific application that provides an electrolyte solution having a pre-selected concentration of at least one electrolyte for use in at least one electrolyzer of the plant. The production can be mobile so it can be provided at different sites to make the same type of solutions or different solutions specific to the needs of the plants it may support. Some embodiments can utilize an electrolyte material handling device that also modular and mobile. Other embodiments can be configured to utilize an on-site electrolyte material handling device.

Abstract: In various embodiments, a tunable optical surface includes a dielectric substrate layer with an array of elongated metal rails extending from the dielectric substrate parallel to one another and spaced from one another to form channels therebetween. The channels are etched deeper into the dielectric substrate to form extended-depth channels. The depth of each extended-depth channel is greater than the height of adjacent elongated metal rails. The dimensions of the elongated metal rails and the extended-depth channels therebetween may be subwavelength with respect to an operational bandwidth. A tunable dielectric material that has a tunable refractive index, such as liquid crystal, is positioned within the extended-depth channels between adjacent elongated metal rails.

Abstract: A micro-dosing oil dispenser with the ability to dispense multiple doses after the user rapidly depresses a dispensing button. The oil dispenser may vibrate upon completion of the doses. The oil dispenser may have a felt tip for better absorption.

Abstract: A safety jacket (10) comprising a buoyant vest (12) including a front portion (16) to be located adjacent the chest of a wearer and a rear portion (18) to be located adjacent the back of the wearer. A rod support is provided comprising a support member (32) pivotally connected to a lower edge of the front portion (16) having an aperture (34) for receiving an end of a fishing rod.

Abstract: An onsite purification plant/system to delivery high and ultra high purity product, such as, process chemicals, industrial and specialty gases to manufacturing processes within the onsite plant turndown ratio from 0% to 100% while preserving the predetermined purity of the supplied substances within a predefined specification range is provided. Preserving liquid/vapor ratio in at least one of the purification means/units ensuring that product purity range stays unchanged is achieved by redirecting the product back into the onsite purification plant/system.

Abstract: The present invention provides methods for inhibiting complement activation and uses thereof. More specifically, the present invention provides methods for inhibiting complement activation using inorganic polyphosphates of at least 10 phosphate units. The polyphosphates inhibit complement activation by one or more of: binding to the C6 complement protein, C1-esterase inhibitor (C1-inh), factor H or factor B; enhancing the activity of C1-inh; interfering with C1s-mediated cleavage of C2; destabilizing the C5b-6 complement protein complex; interfering with C5b,6 interaction with C7; interfering with binding of C5b-7 to a cell membrane; interfering with integration of C5b-7 into a cell membrane; interfering with binding of C5b-8 to a cell membrane; interfering with integration of C5b-8 into a cell membrane; destabilizing the membrane attack complex (MAC); or reducing the amount of C5b-9 deposited on a cell surface.

Abstract: The present invention provides methods for inhibiting complement activation and uses thereof. More specifically, the present invention provides methods for inhibiting complement activation using inorganic polyphosphates of at least 10 phosphate units. The polyphosphates inhibit complement activation by one or more of: binding to the C6 complement protein, C1-esterase inhibitor (C1-inh), factor H or factor B; enhancing the activity of C1-inh; interfering with C1s-mediated cleavage of C2; destabilizing the C5b-6 complement protein complex; interfering with C5b,6 interaction with C7; interfering with binding of C5b-7 to a cell membrane; interfering with integration of C5b-7 into a cell membrane; interfering with binding of C5b-8 to a cell membrane; interfering with integration of C5b-8 into a cell membrane; destabilizing the membrane attack complex (MAC); or reducing the amount of C5b-9 deposited on a cell surface.

Abstract: An onsite purification plant/system to delivery high and ultra high purity product, such as, process chemicals, industrial and specialty gases to manufacturing processes within the onsite plant turndown ratio from 0% to 100% while preserving the predetermined purity of the supplied substances within a predefined specification range is provided. Preserving liquid/vapor ratio in at least one of the purification means/units ensuring that product purity range stays unchanged is achieved by redirecting the product back into the onsite purification plant/system.

Abstract: An onsite purification plant/system to delivery high and ultra high purity product, such as, process chemicals, industrial and specialty gases to manufacturing processes within the onsite plant turndown ratio from 0% to 100% while preserving the predetermined purity of the supplied substances within a predefined specification range is provided. Preserving liquid/vapor ratio in at least one of the purification means/units ensuring that product purity range stays unchanged is achieved by redirecting the product back into the onsite purification plant/system.

Abstract: The present invention provides methods for inhibiting complement activation and uses thereof. More specifically, the present invention provides methods for inhibiting complement activation using polyphosphates.

Abstract: An onsite purification plant/system to delivery high and ultra high purity product, such as, process chemicals, industrial and specialty gases to manufacturing processes within the onsite plant turndown ratio from 0% to 100% while preserving the predetermined purity of the supplied substances within a predefined specification range is provided. Preserving liquid/vapor ratio in at least one of the purification means/units ensuring that product purity range stays unchanged is achieved by redirecting the product back into the onsite purification plant/system.

Abstract: A solid biomass-to-energy combustion method includes introducing an oxygen containing gas into a combustion chamber of a suspension furnace to form a flow of gas through the combustion chamber; injecting a particulate solid biomass fuel into the combustion chamber through a port in the furnace wall and into the gas flow, and combusting the particulate solid biomass fuel in the gas flow to form a flame in the gas flow.

Abstract: The present invention relates generally to methods of for the prevention and treatment for renal disease. In particular, the invention relates to methods of prevention and treatment of mammals, including humans, which are at risk of developing renal failure. This is generally in the field of treatment or prevention of acute renal failure by administration of the anti-apoptotic molecule survivin. The invention also includes the treatment of kidney transplants (renal allografts) to prolong survival of the graft during cold ischemia and immediately after transplantation.

Abstract: The present invention relates generally to methods of for the prevention and treatment for renal disease. In particular, the invention relates to methods of prevention and treatment of mammals, including humans, which are at risk of developing renal failure. This is generally in the field of treatment or prevention of acute renal failure by administration of the anti-apoptotic molecule survivin. The invention also includes the treatment of kidney transplants (renal allografts) to prolong survival of the graft during cold ischemia and immediately after transplantation.

Abstract: In the present invention the in vivo role of the N-terminal lectin-like domain of thrombomodulin was studied by using homologous recombination in murine ES cells to create mutant mice that lack this region of thrombomodulin. Phenotypic analysis shows that said mice respond identically to their wild type littermates following pro-coagulant challenges meaning that the protein C pathway is not altered by the mutation. However, following several inflammatory stimuli, it was observed that the mutant mice showed an elevated neutrophil extravasation in several organs. In the present invention it is found that leukocyte adhesion could be abrogated by addition of recombinant lectin-domain meaning that said domain has direct anti-inflammatory properties which means that the lectin-like domain can be used to manufacture a medicament useful for the treatment of a variety of inflammatory disease processes.

Abstract: The process removes from a diluted gas one or more fluorine compounds present at a first concentration in the diluted gas and concentrates the fluorine compounds. This is done by directly contacting the diluted gas with a cryogenic liquid having a temperature less than or equal to about −150° F., thereby producing a vapor lean in the fluorine compounds and liquid enriched with the fluorine compounds at a second concentration. The second concentration is greater than the first concentration.

Abstract: Disclosed are compositions for and a method for controlling waterhyacinth. The compositions and method utilize the fungus Cercospora rodmanii Conway.